Device investigation details: information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device number lot 30712249l, and no internal actions related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.(b)(4).
|
On 12-jan-2023, additional information was received indicating the adverse event was discovered during use of biosense webster products.The patient¿s outcome from the adverse event was reported as fully recovered.A smartablate generator was used with the correct catheter settings selected on the generator and the pump flow setting was normally controlled by the generator.No error messages observed on biosense webster equipment during the procedure.A transseptal puncture was not performed.No ablation was performed before noticing the pericardial effusion.No evidence of evidence of steam pop.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#(b)(4).
|